Puma Biotechnology, Inc. (PBYI)
9.83
-0.69
(-6.56%)
USD |
NASDAQ |
Oct 16, 16:00
9.83
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Net Income (TTM) : 26.72M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.72M |
| March 31, 2026 | 24.38M |
| December 31, 2025 | 31.11M |
| September 30, 2025 | 36.98M |
| June 30, 2025 | 48.45M |
| March 31, 2025 | 38.07M |
| December 31, 2024 | 30.28M |
| September 30, 2024 | 23.24M |
| June 30, 2024 | 8.72M |
| March 31, 2024 | 15.38M |
| December 31, 2023 | 21.59M |
| September 30, 2023 | 3.717M |
| June 30, 2023 | -2.439M |
| March 31, 2023 | 4.806M |
| December 31, 2022 | 0.002M |
| September 30, 2022 | 9.832M |
| June 30, 2022 | -34.48M |
| March 31, 2022 | -48.96M |
| December 31, 2021 | -29.03M |
| September 30, 2021 | -48.25M |
| June 30, 2021 | -35.04M |
| March 31, 2021 | -26.54M |
| December 31, 2020 | -60.00M |
| September 30, 2020 | -56.20M |
| June 30, 2020 | -41.62M |
| Date | Value |
|---|---|
| March 31, 2020 | -82.44M |
| December 31, 2019 | -75.60M |
| September 30, 2019 | -95.10M |
| June 30, 2019 | -92.41M |
| March 31, 2019 | -99.32M |
| December 31, 2018 | -113.58M |
| September 30, 2018 | -146.98M |
| June 30, 2018 | -209.96M |
| March 31, 2018 | -243.46M |
| December 31, 2017 | -291.98M |
| September 30, 2017 | -300.58M |
| June 30, 2017 | -289.18M |
| March 31, 2017 | -277.94M |
| December 31, 2016 | -276.05M |
| September 30, 2016 | -265.05M |
| June 30, 2016 | -259.69M |
| March 31, 2016 | -257.78M |
| December 31, 2015 | -239.26M |
| September 30, 2015 | -225.06M |
| June 30, 2015 | -200.49M |
| March 31, 2015 | -174.64M |
| December 31, 2014 | -141.98M |
| September 30, 2014 | -110.43M |
| June 30, 2014 | -88.87M |
| March 31, 2014 | -62.67M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Anika Therapeutics, Inc. | -3.121M |
| Arcutis Biotherapeutics, Inc. | 28.52M |
| Olema Pharmaceuticals, Inc. | -204.57M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |